HHC
ORGO icon

Hutchin Hill Capital’s Organogenesis Holdings ORGO Stock Holding History

Hutchin Hill Capital’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,490,000
Closed -$14.7M – 986
2017
Q1 		$14.7M Buy
+1,490,000
New +$14.7M 0.4% 53

Other funds holding ORGO

AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Hutchin Hill Capital's ORGO Position: Q2 2017 in Review

Hutchin Hill Capital sold out of Organogenesis Holdings (ORGO) in Q2 2017, closing a stake of 1,490,000 shares — an estimated $14.7M sold.

Hutchin Hill Capital first reported a position in ORGO in Q1 2017 and held it in 1 quarter. The position peaked at $14.7M in Q1 2017. 18 funds tracked by Wall St. Rank hold ORGO as of Q2 2017.

  • Hutchin Hill Capital reported no remaining Organogenesis Holdings position as of Q2 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 1,490,000 Organogenesis Holdings shares in Q2 2017, an estimated $14.7M.
  • Hutchin Hill Capital first reported a position in Organogenesis Holdings in Q1 2017 and held it in 1 quarter.
  • Hutchin Hill Capital's Organogenesis Holdings position peaked at $14.7M in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2017.

Based on Hutchin Hill Capital's 13F filing for Q2 2017, filed 14 Aug 2017.